C9176 — Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose
C9176 is a HCPCS Level II code for tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose. It belongs to the Outpatient Prospective Payment System section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for C9176
- Long descriptor
- Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose
- Short descriptor
- Dom nonheu tc99m add-on/dose
- Added
- January 1, 2026
- BETOS
- Y1
- Pricing indicator
- 53 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Statute.
Codes adjacent to C9176
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If C9176 is not quite right, the correct code is very often within a few positions of it.
- C9168Injection, mirikizumab-mrkz, 1 mgterminated
- C9169Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramterminated
- C9170Injection, tarlatamab-dlle, 1 mgterminated
- C9171Injection, pegulicianine, 1 mgterminated
- C9172Injection, fidanacogene elaparvovec-dzkt, per therapeutic doseterminated
- C9173Injection, filgrastim-txid (nypozi), biosimilar, 1 microgramterminated
- C9174Injection, datopotamab deruxtecan-dlnk, 1 mgterminated
- C9175Injection, treosulfan, 50 mgterminated
- C9248Injection, clevidipine butyrate, 1 mgterminated
- C9250Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
- C9254Injection, lacosamide, 1 mg
- C9257Injection, bevacizumab, 0.25 mg
- C9275Injection, hexaminolevulinate hydrochloride, 100 mg, per study doseterminated
- C9285Lidocaine 70 mg/tetracaine 70 mg, per patch
- C9290Injection, bupivacaine liposome, 1 mgterminated
- C9293Injection, glucarpidase, 10 units
Questions about C9176
What is HCPCS code C9176?
C9176 is a HCPCS Level II code for tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose. It sits in the Outpatient Prospective Payment System section.
Does Medicare cover C9176?
The CMS HCPCS file marks C9176 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.